AU2016204522A1 - Tuberous Sclerosis treatment - Google Patents
Tuberous Sclerosis treatmentInfo
- Publication number
- AU2016204522A1 AU2016204522A1 AU2016204522A AU2016204522A AU2016204522A1 AU 2016204522 A1 AU2016204522 A1 AU 2016204522A1 AU 2016204522 A AU2016204522 A AU 2016204522A AU 2016204522 A AU2016204522 A AU 2016204522A AU 2016204522 A1 AU2016204522 A1 AU 2016204522A1
- Authority
- AU
- Australia
- Prior art keywords
- tuberous sclerosis
- sclerosis treatment
- treatment
- tuberous
- documet18
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Documet18-28/06/2016 Rapamycin derivatives for use in the treatment of neurocutaneous disorders.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2016204522A AU2016204522C1 (en) | 2006-02-02 | 2016-06-29 | Tuberous Sclerosis treatment |
AU2017218980A AU2017218980B2 (en) | 2006-02-02 | 2017-08-22 | Tuberous Sclerosis treatment |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0602123.2 | 2006-02-02 | ||
GB0603568.7 | 2006-02-22 | ||
GB0604593.4 | 2006-03-07 | ||
GB0605760.8 | 2006-03-22 | ||
GB0609698.6 | 2006-05-16 | ||
AU2011205053A AU2011205053B2 (en) | 2006-02-02 | 2011-07-28 | Tuberous Sclerosis treatment |
AU2013205754A AU2013205754C1 (en) | 2006-02-02 | 2013-05-07 | Tuberous Sclerosis treatment |
AU2016204522A AU2016204522C1 (en) | 2006-02-02 | 2016-06-29 | Tuberous Sclerosis treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2013205754A Division AU2013205754C1 (en) | 2006-02-02 | 2013-05-07 | Tuberous Sclerosis treatment |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2017218980A Division AU2017218980B2 (en) | 2006-02-02 | 2017-08-22 | Tuberous Sclerosis treatment |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2016204522A1 true AU2016204522A1 (en) | 2016-07-14 |
AU2016204522B2 AU2016204522B2 (en) | 2017-06-29 |
AU2016204522C1 AU2016204522C1 (en) | 2017-12-07 |
Family
ID=45420285
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2011205053A Active AU2011205053B2 (en) | 2006-02-02 | 2011-07-28 | Tuberous Sclerosis treatment |
AU2012268891A Active AU2012268891B2 (en) | 2006-02-02 | 2012-12-24 | Tuberous Sclerosis treatment |
AU2013205754A Active AU2013205754C1 (en) | 2006-02-02 | 2013-05-07 | Tuberous Sclerosis treatment |
AU2016204522A Active AU2016204522C1 (en) | 2006-02-02 | 2016-06-29 | Tuberous Sclerosis treatment |
AU2017218980A Active AU2017218980B2 (en) | 2006-02-02 | 2017-08-22 | Tuberous Sclerosis treatment |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2011205053A Active AU2011205053B2 (en) | 2006-02-02 | 2011-07-28 | Tuberous Sclerosis treatment |
AU2012268891A Active AU2012268891B2 (en) | 2006-02-02 | 2012-12-24 | Tuberous Sclerosis treatment |
AU2013205754A Active AU2013205754C1 (en) | 2006-02-02 | 2013-05-07 | Tuberous Sclerosis treatment |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2017218980A Active AU2017218980B2 (en) | 2006-02-02 | 2017-08-22 | Tuberous Sclerosis treatment |
Country Status (1)
Country | Link |
---|---|
AU (5) | AU2011205053B2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6565831B1 (en) * | 1999-02-24 | 2003-05-20 | Oncolytics Biotech Inc. | Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
US20050070567A1 (en) * | 2002-08-12 | 2005-03-31 | The Regents Of The University Of Michigan | Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
CA2514061A1 (en) * | 2003-02-14 | 2004-09-02 | Combinatorx, Incorporated | Combination therapy for the treatment of immunoinflammatory disorders |
-
2011
- 2011-07-28 AU AU2011205053A patent/AU2011205053B2/en active Active
-
2012
- 2012-12-24 AU AU2012268891A patent/AU2012268891B2/en active Active
-
2013
- 2013-05-07 AU AU2013205754A patent/AU2013205754C1/en active Active
-
2016
- 2016-06-29 AU AU2016204522A patent/AU2016204522C1/en active Active
-
2017
- 2017-08-22 AU AU2017218980A patent/AU2017218980B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2017218980A1 (en) | 2017-09-07 |
AU2012268891A1 (en) | 2013-01-24 |
AU2011205053B2 (en) | 2013-02-07 |
AU2011205053A1 (en) | 2011-08-25 |
AU2016204522B2 (en) | 2017-06-29 |
AU2013205754A1 (en) | 2013-05-30 |
AU2013205754C1 (en) | 2018-01-04 |
AU2017218980B2 (en) | 2019-03-28 |
AU2016204522C1 (en) | 2017-12-07 |
AU2012268891B2 (en) | 2014-07-03 |
AU2013205754B2 (en) | 2016-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX339116B (en) | Tuberous sclerosis treatment. | |
IL195256A0 (en) | Compositions of r(+)and s(-)pramipexole and methods of using the same | |
EP1893216A4 (en) | Methods and compositions for the treatment of ocular disorders | |
EP1987141B8 (en) | Compositions suitable for treating collagen-mediated diseases | |
IL191283A (en) | Compositions for the treatment of ophthalmic disorders | |
AU2006224295A8 (en) | N- (N-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain | |
WO2007146965A3 (en) | Compounds for the treatment of periodontal disease | |
EP1883438A4 (en) | Apparatus and techniques for reducing the effects of general anesthetics | |
ZA200706791B (en) | Isoxazole combretasin derivatives for the treatment of disorders | |
PL1920781T3 (en) | Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors | |
WO2007081751A9 (en) | Compositions and methods for the treatment of cancer | |
MY147247A (en) | Organic compounds and their uses | |
IL195906A (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
SI2024368T1 (en) | 6,7,8,9-tetrahydro-5h-pyrimidoš4,5-dćazepin-4-ylć-amine derivatives as modulators of trpv1 for the treatment of pain | |
HK1139861A1 (en) | Pde7 inhibitors for use in the treatment of movement disorders 7(pde7) | |
WO2007101161A8 (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
IL198112A0 (en) | 3-aminoimidazo [1,2-a]pyridine derivatives having an sglt1-and sglt2-inhibiting action for the treatment of type 1 and type 2 diabetes | |
WO2007136741A3 (en) | N-desmethyl-doxepin and methods of using the same to treat sleep disorders | |
TW200716153A (en) | Mitotic kinesin inhibitors and methods of use thereof | |
AU2006243194A8 (en) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility | |
WO2006130493A3 (en) | Heterocycles useful as modulators of ion channels | |
TW200716561A (en) | P38 inhibitors and methods of use thereof | |
WO2007015173A3 (en) | Inflammation | |
SI1920781T1 (en) | Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 22 AUG 2017 |
|
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 22 AUG 2017 |
|
FGA | Letters patent sealed or granted (standard patent) |